Skip to content

Scalici will oversee the day-to-day operations of the division, which employs five gynecologic oncologists, two nurse practitioners and their support staff, and is the largest gynecologic oncology practice on the upper Gulf Coast.

Published Jul 29th, 2019

By Carol McPhail

CMcPhail@health.southalabama.edu

Dr. Jennifer Scalici has been named chief of the gynecologic oncology service at USA Health Mitchell Cancer Institute.

Scalici will oversee the day-to-day operations of the division, which employs five gynecologic oncologists, two nurse practitioners and their support staff, and is the largest gynecologic oncology practice on the upper Gulf Coast.

“During her years at MCI, Dr. Scalici has excelled in all areas of academic medicine,” said Dr. Rodney P. Rocconi, interim director at the Mitchell Cancer Institute. “I look forward to her leadership and vision in moving the gynecologic oncology division forward as we continue to provide the highest level of patient care while searching for new and improved treatments for cancer.”

Since joining the Mitchell Cancer Institute in 2012, Scalici has built a clinical practice emphasizing minimally invasive and robotic surgery. She also conducts basic and translational research as director of the gynecologic oncology research team. Her current research, funded by a grant from the U.S. Department of Defense, examines the effectiveness of a novel compound in the prevention of ovarian cancer.

Scalici earned her medical degree from the University of Alabama at Birmingham before completing a residency at Northwestern University McGraw Medical Center in Chicago and a fellowship at the University of Virginia Health System in Charlottesville, Va.

Recent News

Yorktown covid vaccine
More than 400 vaccines given at community-based clinic

Momentum for the first community-based clinic began to build after Yorktown’s minister, the Rev. Christopher Williams, connected with Natalie Fox, DNP, an assistant administrator and chief nursing officer for USA Health Physicians Group who is leading COVID-19 testing and vaccines efforts.

Posted 3 days agoRead Story >
Back to News Listing
This link will open in a new tab or window.